OCUCLEAR

LOE Approaching

oxymetazoline hydrochloride

Bayer
NDAOPHTHALMICSOLUTION/DROPS
Approved
May 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Clinical Trials (1)

NCT03954444Phase 3Completed

A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

Started Apr 2019
1,105 enrolled
Rosacea
Company
Bayer
Bayer
LEVERKUSEN, Germany
4 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers